Trials / Completed
CompletedNCT01423474
Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment Time
Randomized Phase II Study of 2 Hypofractionated Radiotherapy Schedules for Low- and Intermediate-Risk Prostate Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 152 (actual)
- Sponsor
- CancerCare Manitoba · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the toxicity of two new radiation schedules for the treatment of prostate cancer. Patients will be randomized to receive 5 treatments delivered every other day over 11 days, or once per week over 29 days. Both of these schedules are shorter than the standard treatment which is usually 39 treatments over 8 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Image-guided radiotherapy | 40 Gy / 5 fractions / 11 days |
| RADIATION | Image-guided radiotherapy | 40 Gy / 5 fractions / 29 days |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2019-08-01
- Completion
- 2019-08-01
- First posted
- 2011-08-26
- Last updated
- 2024-02-23
Locations
3 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT01423474. Inclusion in this directory is not an endorsement.